3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel
Citation
Cipriani, Andrea and Cowen, Philip J. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel. Lancet Psychiatry 2018-06-01, Volume 5, Issue 6, Pages 453-455
Abstract
Comment: This current study describes the therapeutic use of MDMA by committed experts in a specialised setting in a small group of participants, most of whom self-referred for the trial. The unmet need for better PTSD treatment, particularly in veterans and first responders, is undoubted. However, the generalisability of the benefit of MDMA-assisted psychotherapy to more mainstream psychiatry remains to be established, recalling perhaps the famous American watchword, “Will it play in Peoria?”
Description
Published online at: https://doi.org/10.1016/S2215-0366(18)30170-6
Eligible users can access the full text via NHS OpenAthens at [https://www.clinicalkey.com/#!/content/journal/1-s2.0-S2215036618301706] (login required).
Collections
- Anxiety Disorders [52]